In the current study, the neuroprotective effects of the MNT BNN27, a novel DHEA derivative, were assessed in mouse motor neurons co-cultured with human astrocytes from ALS patients with a SOD1 mutation and in the G93A SOD1 mouse model of ALS. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.